Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic Mesenchymal Bone Marrow Cells

mesenchymal stem cells · Stemedica Cell Technologies, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Allogeneic Mesenchymal Bone Marrow Cells, covering 2017-04-27 to 2018-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke [Phase 1, Phase 2]

See pricing